Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SHA: 600196)

Shanghai Fosun Pharmaceutical (Group) Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jan 3, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	59,198	61,592	86,922	113,862	125,791	65,086
Market Cap Growth	-5.62%	-29.14%	-23.66%	-9.48%	93.27%	12.32%
Enterprise Value	90,233	89,228	110,109	134,998	147,717	86,903
Last Close Price	24.65	24.74	34.35	47.08	51.64	25.26
PE Ratio	31.51	25.81	23.30	24.08	34.34	19.59
Forward PE	20.98	21.48	19.36	20.43	30.68	17.62
PS Ratio	1.59	1.49	1.98	2.92	4.15	2.28
PB Ratio	1.39	1.09	1.61	2.35	2.74	1.66
P/TBV Ratio	2.82	2.88	3.99	5.83	6.40	4.35
P/OCF Ratio	16.80	18.04	20.61	28.91	48.76	20.20
PEG Ratio	1.02	1.02	1.02	1.31	1.31	0.89
EV/Sales Ratio	2.17	2.16	2.51	3.46	4.87	3.04
EV/EBITDA Ratio	15.78	23.25	19.87	32.27	36.18	23.64
EV/EBIT Ratio	37.62	75.34	32.19	53.22	56.42	36.52
EV/FCF Ratio	-436.03	-	-	-	-	-
Debt / Equity Ratio	0.59	0.62	0.56	0.53	0.52	0.56
Debt / EBITDA Ratio	6.08	8.54	5.25	5.86	5.63	5.74
Asset Turnover	0.37	0.38	0.44	0.44	0.38	0.39
Inventory Turnover	2.84	3.01	3.76	3.82	3.03	3.20
Quick Ratio	0.68	0.73	0.78	0.75	0.71	0.89
Current Ratio	0.92	1.00	1.06	1.04	1.01	1.17
Return on Equity (ROE)	4.79%	5.23%	7.70%	10.55%	9.25%	10.28%
Return on Assets (ROA)	1.33%	0.67%	2.13%	1.79%	2.05%	2.03%
Return on Capital (ROIC)	1.64%	0.84%	2.70%	2.21%	2.50%	2.52%
Earnings Yield	3.17%	3.87%	4.29%	4.15%	2.91%	5.10%
FCF Yield	-0.32%	-3.12%	-1.92%	-0.91%	-1.48%	-1.14%
Dividend Yield	1.12%	1.09%	1.22%	1.19%	0.83%	1.54%
Payout Ratio	97.52%	102.89%	63.64%	40.48%	50.09%	56.13%
Buyback Yield / Dilution	-0.42%	-2.40%	-1.74%	-	-	-1.57%
Total Shareholder Return	0.70%	-1.31%	-0.51%	1.19%	0.83%	-0.03%

Source: S&P Capital IQ. Standard template. Financial Sources.